Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genome-wide significant breast cancer locus at 12q15

MJ Madsen, S Knight, C Sweeney, R Factor… - … Biomarkers & Prevention, 2018 - AACR
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …
被引用次数：15 相关文章

Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at …

MJ Madsen, S Knight, C Sweeney, R Factor… - … & Prevention: a …, 2018 - europepmc.org
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …
[HTML] nih.gov

[HTML][HTML] Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at …

MJ Madsen, S Knight, C Sweeney… - … & prevention: a …, 2018 - ncbi.nlm.nih.gov
Background Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …

Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at …

MJ Madsen, S Knight, C Sweeney… - … & prevention: a …, 2018 - pubmed.ncbi.nlm.nih.gov
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …

Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genome-wide significant breast cancer locus at 12q15.

MJ Madsen, S Knight, C Sweeney, R Factor, M Salama… - 2018 - cabidigitallibrary.org
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …

Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genome-Wide significant breast cancer locus at 12q15

MJ Madsen, S Knight, C Sweeney… - Cancer …, 2018 - mayoclinic.elsevierpure.com
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …
[PDF] researchgate.net

[PDF][PDF] Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at …

MJ Madsen, S Knight, C Sweeney, R Factor, M Salama… - researchgate.net
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …

Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at …

MJ Madsen, S Knight, C Sweeney, R Factor… - … & Prevention: a …, 2018 - europepmc.org
Background: Breast tumor subtyping has failed to provide impact in susceptibility genetics.
The PAM50 assay categorizes breast tumors into: Luminal A, Luminal B, HER2-enriched …